| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 13 Aug 2025 | 8 Aug 2025 |
| Coral Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 inter alia to consider and approve 1. To consider and adopt Unaudited Standalone Financial Results of the Company for the quarter ended June 30 2025 in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. 2. To fix date time for convening the 43rd Annual General Meeting and to approve the Notice of Annual General Meeting 3. To recommend appointment of Statutory Auditors of the Company upon completion of term of existing statutory auditor M/s M. A. Parekh & Associates Chartered Accountants 4. To consider alteration of Object clause of the Memorandum of Association. 5. Any other business with the permission of chairman. | ||
| Board Meeting | 30 May 2025 | 22 May 2025 |
| Coral Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that the meeting of the Board of Directors of the Company has been scheduled to be held on Friday May 30 2025 inter alia for the following business (es): 1. To consider and approve standalone audited financial results for the quarter and financial year ended March 31 2025. 2. To recommend final dividend on equity shares of the Company for the year ended March 31 2025 if any 3. To appoint Secretarial Auditor for five years beginning from F.Y. 2025-2026. 4. To appoint Internal Auditor for the F.Y 2025-26. 5. To appoint Cost Auditor for the F.Y 2025-26 6. Any other business with the permission of chairman Thanking you. Financial Result for the financial year ending March 31, 2025 Board meeting held on May 30, 2025 (As Per BSE Announcement Dated on :30.05.2025) | ||
| Board Meeting | 13 Feb 2025 | 5 Feb 2025 |
| CORAL LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 inter alia to consider and approve Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024 To consider and adopt the Unaudited Standalone Financial Results for the quarter and nine months ended December 31 2024, with the Limited Review Report in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (As Per BSE Announcement Dated on: 13/02/2025) | ||
| Board Meeting | 14 Nov 2024 | 6 Nov 2024 |
| CORAL LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Financial Result - quarter and half year ended on September 30 2024 with limited review report thereon in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable provisions, the Board of Directors of the Company in its meeting held on Thursday, 14th November 2024 at the Corporate Office of the Company situated at 3B, Patanwala Compound, Opp. Shreyas Cinema, L.B.S. Marg, Ghatkopar (W), Mumbai- 400086 at 2:30 P.M, has inter alia considered and approved: 1. The Unaudited Standalone Financial Results along with Statement of Asset & Liabilities and Cash Flow Statement for the quarter and half year ended September 30, 2024 and took note of the Limited Review Report submitted by M A Parekh & Associates, Statutory Auditor of the Company. (As Per BSE Announcement Dated on: 14/11/2024) | ||
| Board Meeting | 24 Sep 2024 | 19 Sep 2024 |
| CORAL LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/09/2024 inter alia to consider and approve Dear Sir/Madam Pursuant to Régulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that the meeting of the Board of Directors of the Company has been scheduled to be held on Tuesday September 24 2024 at the Registered Office of the Company at 3B Patanwala Compound Opp Shreyas Cinema L.B.S. Marg Ghatkopar (W) Mumbai- 400 086 inter alia for the following business (es): 1. To approve Cost Audit Report in Form CRA -3 for the Financial Year 2023-2024. 2. Any other business with the permission of chairman. Thanking You. Dear Sir/Madam, We are pleased to inform you that the Board of Directors in their meeting of the of the Company held on Tuesday, September 24, 2024, at the Registered Office of the Company situated at 3B, Patanwala Compound, Opp Shreyas Cinema, L.B.S. Marg, Ghatkopar (W) Mumbai- 400 086 at 12.00 noon, have inter alia transacted the following business: 1. Approval of Cost Audit Report in Form CRA -3 for the Financial Year 2023-2024. The meeting commenced at 12.00 Noon and was concluded by 1.30 PM on the same day. Kindly take the same on record. Thanking You. Read less.. (As Per BSE Announcement Dated on 24.09.2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.